Suman Kumar Samanta

About

Dr. Suman Kumar Samanta, with a master’s degree in organic chemistry and a PhD in biochemistry from the CSIR-Indian Institute of Chemical Biology, Kolkata, has built an illustrious career in biomedical research. Following post-doctoral studies at the University of Pittsburgh (2014–2016), where he gained expertise in advanced biomedical sciences, Dr. Samanta joined the Institute of Advanced Study in Science and Technology (IASST), India, as Scientist C in 2017, contributing significantly to natural product chemistry. Currently a senior research faculty member at Assam down town University, he leads pioneering efforts in molecular pharmacology, drug discovery, and cancer biology. His research, focused on tumor biology and the therapeutic potential of indigenous medicinal plants, has resulted in over 40 publications in top-tier journals such as Journal of the National Cancer Institute (JNCI), Journal of Medicinal Chemistry, Cancer Letters, International Journal of Cancer, and Pharmacological Research and includes one international and two national patents. Dr. Samanta’s work exemplifies the synthesis of traditional knowledge with modern science, offering innovative solutions for cancer treatment and beyond.

Employment

• Assam Down Town University Associate Professor
  2023 - Present
• Institute of Advanced Study in Science and Technology Scientist
  2017 - 2023
• University of Pittsburgh PDF
  2014 - 2016
• Indian Institute of Chemical Biology CSIR Research Associate
  2014 - 2014

Education

• Indian Institute of Chemical Biology CSIR PhD
  2007 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (49)

• Structural, photophysical, and electrochemical characterization with cytotoxic evaluation of N-methylated pyridinium–vinyl–arene dyes in breast cancer cells
  Journal of Molecular Structure 2026 DOI: 10.1016/j.molstruc.2026.146214
  +Save
• Fusobacterium nucleatum in oral squamous cell carcinoma: molecular mechanisms, tumor microenvironment and translational implications
  Archives of Microbiology 2026 DOI: 10.1007/s00203-026-04991-7
  +Save
• Phytochemicals as Radioprotective and Radiosensitizing Agents in Cancer Radiotherapy: Advances, Challenges, and Future Perspectives
  Planta Medica 2026 DOI: 10.1055/a-2654-6072
  +Save
• Correlation of specific addictions with cancer sites identified among patients in Northeast India
  Scientific Reports 2025 DOI: 10.1038/s41598-025-12939-y
  +Save
• Exopolysaccharides of Potential Probiotic Bacteria Bacillus subtilis BB2: Characterization, Antioxidant and Antibiofilm Activities
  Food Biotechnology 2025 DOI: 10.1080/08905436.2025.2539363
  +Save
• Comparative analysis of endophytic bacterial localization and microbiome diversity in plant varieties under varied growth conditions through microscopic imaging and sequencing techniques
  Frontiers in Microbiology 2025 DOI: 10.3389/fmicb.2025.1568209
  +Save
• Oncogene Downregulation by Mahanine Suppresses Drug-Sensitive and Drug-Resistant Lung Cancer and Inhibits Orthotopic Tumor Progression
  Cancers 2024 DOI: 10.3390/cancers16213572
  +Save
• Finding the ajoene sweet-spot: structure-activity relations that govern its blood stability and cancer cytotoxicity.
  ChemMedChem 2024 DOI: 10.1002/cmdc.202400087
  +Save
• Mahanine mediated therapeutic inhibition of estrogen receptor-α and CDK4/6 expression, decipher the chemoprevention-signaling cascade in preclinical model of breast cancer
  Journal of Ethnopharmacology 2024 DOI: 10.1016/j.jep.2023.117235
  +Save
• Kaempferol 3-O-rutinoside from Antidesma acidum Retz. Stimulates glucose uptake through SIRT1 induction followed by GLUT4 translocation in skeletal muscle L6 cells
  Journal of Ethnopharmacology 2023 DOI: 10.1016/j.jep.2022.115788
  +Save